Paper
RSC Advances
(CDCl3): d 5.78 ppm (dd, 0.12H, 3JH2–H1 trans ¼ 17.3 Hz and 3JH2– 0.12H, 3JH1 trans–H2 ¼ 17.3 Hz, C1T–H); 5.21 (d, 0.12H, 3JH1–H2
¼
¼ 10.7 Hz, C2T–H); 5.33 (t, 0.88H, 3JH2–H1 ¼ 7.3 Hz, C2E–H 10.7 Hz, C1T–H); 5.09 (m, 2H, C7–H and C12–H); 3.77 (d, 1.77H,
H1 cis
and C2Z–H); 5.23 (d, 0.14H, 3JH1 trans–H2 ¼ 17.3 Hz, C1T–H); 5.20 3JH1–H2 ¼ 7.3 Hz, C1E–H and C1Z–H); 2.11 (m, 8H, C5–H, C6–H,
3
(d, 0.14H, JH1 trans–H2 ¼ 10.7 Hz, C1T–H); 5.09 (m, 1H, C7–H); C10–H, C11–H); 1.80 (s, 1.05H, C4Z–H); 1.71 (s, 2.01H, C4E–H);
3.75 (dd, 1.85H,3 JH1–H2 ¼ 7.2 Hz, C1E–H and C1Z–H); 2.10 (bs, 1.68 (s, 3H, C15–H); 1.61 (s, 6H, C9–H and C14–H); 1.55 (s,
3.67H, C5–H and C6–H); 1.79 (s, 1.07H, C4Z–H); 1.70 (s, 1.87H, 0.40H, C9T–H) and 1.35 (s, 0.40H, C4T–H). 13C NMR (CDCl3):
C4E–H); 1.68 (s, 3H, C10–H), 1.61 (s, 3H, C9–H) and 1.35 (s, d 143.1 (CE3, quaternary); 143.0 (CZ3, quaternary); 140.1 (CT2,
0.41H, C4T–H). 13C NMR (CDCl3): d 143.1 ppm (CE3, quater- CH); 135.9 (CZ8, quaternary); 135.7 (CT8, quaternary); 135.6
nary); 143.0 (CZ3, quaternary); 140.1 (CT2, quaternary); 132.3 (CE8, quaternary); 131.3 and 131.2 (CE13, CZ13 and CT13,
(CZ8, quaternary); 132.1 (CT8, quaternary); 131.9 (CE8, quater- quaternary); 124.3 (CE12, CZ12 and CT12, CH); 123.5 (CE7, CH);
nary); 123.6 (CE7, CH); 123.5 (CT7, CH); 123.4 (CZ7, CH); 117.9 123.4 (CT7, CH); 123.3 (CZ7, CH); 117.9 (CZ2, CH); 117.1 (CE2,
(CZ2, CH); 117.0 (CE2, CH); 114.6 (CT1, CH2); 64.9 (CT3, CH); 114.6 (CT1, CH2); 64.9 (CT3, quaternary); 48.0 (CE1 and CZ1,
quaternary); 48.0 (CE1, CH2); 47.9 (CZ1, CH2); 40.1 (CT5, CH2); CH2); 40.1 (CT5, CH2); 39.7 (CT10, CH2); 39.5 (CE5, CH2); 32.1
39.5 (CE5, CH2); 32.1 (CZ5, CH2); 26.7 (CZ6, CH2); 26.4 (CE6, (CZ5, CH2); 26.7 (CE6, CZ6, CZ10, CE10, CH2); 25.6 (C14, CH3);
CH2); 25.6 (CZ10, CE10, CH3); 23.3 (CZ4, CH3); 23.1 (CT4, CH3); 23.3 (CT4, CH3); 23.1 (CE4, CH3); 22.7 (CT6, CH2); 17.6 (C15,
22.8 (CT6, CH2); 17.7 (CT9, CH3); 17.6 (CE9, CH3); 17.6 (CZ9, CH3) CH3); 16.4 (CE4, CH3); 16.0 (C9, CH3) and 15.9 (CZ4, CH3). HRMS
and 16.4 (CE4, CH3). HRMS (APCI): calculated mass for (APCI): mass calculated for
10H18Nꢀ 152.14447; found 152.14438. IR (lm): ymax (cmꢀ1 220.21291. IR (lm): ymax (cmꢀ1) 2968 (]CH–), 2926 (–CH2–),
2969 (]CH–), 2928 (–CH2–), 2884 (–CH2–C–N–), 2098 (–N3), 2856 (–CH2–C–N–), 2097 (–N3), 1665 (–C]C–).
C
15H26Nꢀ 220.20707, found
C
)
1664 (–C]C–).
Synthesis of mixture of allylazides from the geranylgeraniol:
Synthesis of mixture of allylazides from the nerol: (E)-1- (2E,6E,10E)-1-azido-3,7,11,15-tetramethylhexadeca-2,6,10,14-
azido-3,7-dimethylocta-2,6-diene
(6b-E);
(Z)-1-azido-3,7- tetraene
(6d-E);
(2Z,6E,10E)-1-azido-3,7,11,15-tetramethyl-
dimethylocta-2,6-diene (6b-Z) and 3-azido-3,7-dimethylocta- hexadeca-2,6,10,14-tetraene (6d-Z) and (6E,10E)-3-azido-3,7,11,15-
1,6-diene (6b–t). Following the general reaction conditions for tetramethylhexadeca-1,6,10,14-tetraene (6d–t). Following the
the prenylazides synthesis, nerol 5b-Z (100 mg; 0.65 mmol) was general reaction conditions for the prenylazides synthesis, ger-
dissolved in anhydrous toluene (2 mL). Then, DPPA was slowly anylgeraniol 5d (50 mg; 0.17 mmol) was dissolved in anhydrous
added (220 mg, 0.83 mmol) followed by the addition of DBU toluene (1 mL). Then, DPPA was slowly added (58 mg, 0.22 mmol)
(129 mg; 0.83 mmol). Aer 8 h of continuous stirring at room followed by the addition of DBU (34 mg; 0.22 mmol). Aer 8 h of
temperature, the reaction was worked up and puried to afford continuous stirring at room temperature, the reaction was worked
104 mg of colourless oil (isolated yield: 89%). The spectra of 1H up and puried to afford 49 mg of colorless oil (isolated yield:
3
and 13C coincident with spectra obtained of mixture of allylic 92%). 1H NMR (CDCl3): d 5.79 ppm (dd, 0.12H, JH2–H1 trans
azides from the geraniol.
¼
17.3 Hz and 3JH2–H1 cis ¼ 10.7 Hz, C2T–H); 5.34 (t, 0.93H, 3JH2–H1
¼
Synthesis of mixture of allyl azides from the linalool: (E)-1- 7.3 Hz, C2E–H and C2Z–H); 5.23 (d, 0.14H, 3JH1 trans–H2 ¼ 17.3 Hz,
3
azido-3,7-dimethylocta-2,6-diene
(6b-E);
(Z)-1-azido-3,7- C1T–H); 5.20 (d, 0.14H, JH1–H2 ¼ 10.7 Hz, C1T–H); 5.10 (m, 3H,
dimethylocta-2,6-diene (6b-Z) and 3-azido-3,7-dimethylocta- C7–H, C12–H and C17–H); 3.78 (d, 1.78H, 3JH1–H2 ¼ 7.3 Hz, C1E–
1,6-diene (6b–t). Following the general reaction conditions for H); 3.76 (d, 1.78H, 3JH1–H2 ¼ 7.3 Hz, C1Z–H); 2.05 (m, 12H, C5–H,
the prenyl azides synthesis, linalool 5b–t (100 mg; 0.65 mmol) C6–H, C10–H, C11–H, C15–H and C16–H); 1.80 (s, 1.07H, C4Z–H);
was dissolved in anhydrous toluene (2 mL). Then, DPPA was 1.71 (s, 3H, C4E–H); 1.68 (s, 3H, C15–H); 1.61 (s, 9H, C9–H, C14–H
slowly added (220 mg, 0.83 mmol) followed by the addition of and C19–H); 1.55 (s, 3H, C20–H) and 1.35 (s, 0.45H, C4T–H). 13
C
DBU (129 mg; 0.83 mmol). Aer 8 h of continuous stirring at NMR (CDCl3): d 143.2 ppm (CE3, quaternary); 143.1 (CZ3, quater-
room temperature, the reaction was worked up and puried to nary); 140.1 (CT2, quaternary); 136.0 (CZ8, quaternary and CT8,
afford 99 mg of colourless oil (isolated yield: 85%).
The spectra of 1H and 13C coincide with spectra obtained of 131.3 (C18, quaternary); 124.4 (C17, CH); 124.2 (CZ12, CH); 124.2
mixture of allylic azides from the geraniol. (CT12, CH); 124.1 (CE12, CH); 123.5 (CE7, CH); 123.5 (CT7, CH);
quaternary); 135.6 (CE8, quaternary); 135.0 (C13, quaternary);
Synthesis of mixture of allylazides from the farnesol: (2E,6E)- 123.3 (CZ7, CH); 117.9 (CZ2, CH); 117.0 (CE2, CH); 117.0 (CT1, CH2);
1-azido-3,7,11-trimethyldodeca-2,6,10-triene (6c-E); (2Z,6E)-1- 64.9 (CT3, quaternary); 48.1 (CE1, CH2); 48.0 (CZ1, CH2); 40.1 (CT5,
azido-3,7,11-trimethyldodeca-2,6,10-triene (6c-Z) and (E)-3- CH2); 39.7 (C11, CH2); 39.7 (C16, CH2); 39.5 (CE5, CH2); 32.1 (CZ5,
azido-3,7,11-trimethyldodeca-1,6,10-triene (6c–t). Following the CH2); 26.8 (C16, CH2); 26.6 (C10, CH2); 26.4 (CE6 and CZ6, CH2);
general reaction conditions for the prenylazides synthesis, far- 25.7 (C20, CH3); 23.4 (CE4, CH3); 23.2 (CT4, CH3); 22.7 (CT6, CH2);
nesol 5c (300 mg; 1.35 mmol) was dissolved in anhydrous 17.7 (C19, CH3); 16.4 (C14, CH3); 16.0 (CZ4, CH3) and 16.0 (C9,
toluene (4 mL). Then, DPPA was slowly added (355 mg, 1.75 CH3). IR (lm): ymax (cmꢀ1) 2967 (]CH–), 2928 (–CH2–), 2882
mmol) followed by the addition of DBU (270 mg; 1.75 mmol). (–CH2–C–N–), 2096 (–N3), 1660 (–C]C–).
Aer 8 h of continuous stirring at room temperature, the reac-
Synthesis of mixture of allylazides from the phytol: (E)-1-
tion was worked up and puried to afford 284 mg of colourless azido-3,7,11,15-tetramethylhexadec-2-ene (6e-E); (Z)-1-azido-
oil (isolated yield: 85%). 1H NMR (CDCl3): d 5.79 ppm (dd, 3,7,11,15-tetramethylhexadec-2-ene (6e-Z) and (3R)-3-azido-
0.12H, 3JH2–H1 trans ¼ 17.3 Hz and 3JH2–H1 cis ¼ 10.7 Hz, C2T–H); 3,7,11,15-tetramethylhexadec-1-ene (6e–t). Following the
3
5.34 (t, 0.87H, JH2–H1 ¼ 7.3 Hz, C2E–H and C2Z–H); 5.24 (d, general reaction conditions for the prenylazides synthesis,
This journal is © The Royal Society of Chemistry 2017
RSC Adv., 2017, 7, 47527–47538 | 47535